Home \| Site Map \| \| Develop Your Domain Names
	Treating Influenza

Avian Influenza - Bird Flu FAQ
As more and more cases of bird flu are reported, the world faces an immediate threat of a deadly pandemic. Pandemics (Global Disease Outbreaks) are known to be like flash floods. They start abruptly, spread fast and cause a lot of damage all over the world.

Earlier Initiation of Tamiflu® Treatment Improves Clinical Benefits for Children with Influenza
New data show benefits of early treatment with Tamiflu in reducing influenza Illness duration, symptom severity & secondary complications --Treatment initiated within 24 hours of symptom onset provides clinically meaningful improvements, compared with treatment initiated within 24 - 48 hours -- Tamiflu, the leading prescription antiviral flu medication, is indicated for the prevention and treatment of influenza types A and B in patients one year and older.

The Avian Influenza Virus
Avian Influenza: A Great Concern - Avian influenza first occurred in Italy, but has spread around the world. It is an infectious disease caused by strains of the influenza virus.

Anadis' Milk-Based Anti-Influenza (Flu) Virus Antibodies to Provide Immediate Immunity
Anadis Limited (ASX:ANX; OTC: ANDIY), today announced major progress in its anti-flu virus antibody program. The milk- derived anti-flu virus antibodies are all-natural and will provide immediate-acting immune enhancement once deposited topically on mucosal surfaces that come in contact with the influenza virus. Results from human trials are anticipated within 18 months. Addressing both seasonal and avian influenza (bird flu) virus strains, Anadis plans to introduce products using these antibodies (Flubodies) into the market within 2-3 years. This decision follows several successful animal trials with mice, conducted by Anadis and an internationally-recognized influenza research group at the University of Melbourne led by Professor Lorena B...

Influenza Antibody Spray Success: Opens New Approach to Respiratory Disease Control
Anadis Limited (ASX: ANX), a research driven biopharmaceutical company focused on polyclonal antibodies to address human disease, announced today important progress concerning its accelerated program to develop a nasal antibody spray to provide immediate post-exposure prophylaxis against a range of influenza viruses.

Bird Flu and Flu Pandemic -- How to Reduce the Risk of Infections
Infection prevention more important than ever, says world experts -- but research shows many fall short in practicing good hygiene in daily lives. NO-GERMS™ Portable Hand Sanitizer has been proven effective against bird flu (Avian Flu H5N1 Virus) on the hands, in independent tests at Retroscreen Virology, Queen Mary's School of Medicine and Dentistry, University of London.

H5N1 Virus Replikin Gene Counts Indicate a New More Virulent Influenza Cycle Has Begun
Replikins Ltd. has found that H5N1 virus replikin peak gene counts in 2007 in Hong Kong, Russia, Indonesia, Vietnam and Israel indicate that a new replikin cycle has begun. The mean replikin count exceeded the maximum of the previous cycle identified by the company. Although several conditions are required to produce a pandemic, the increase in replikin count, a feature of each of the last three pandemics, is now in the range of the increase seen in the 1918 H1N1 pandemic.

Facts about Influenza Flu Medications
Influenza, also known as flu is an infectious disease that spreads through upper airways and lungs in mammals. Common symptoms of influenza found are fever, sore throat, muscle pains, severe headache, coughing, weakness, and fatigue.

Tamiflu for Flu Prevention and Treatment
Tamiflu flu medicine is the first choice of doctors. It is approved for prevention and treatment of influenza in adults as well as in children aged 1 year and older.

Lethal Human H5N1 Influenza Virus Replikin Gene Still Upregulated
Replikins, Ltd. today announced its latest findings regarding the virus replikin count in human H5N1 influenza virus. The company's software-driven analysis has found that the prevalence of these sequences has remained high in Indonesia; in addition, higher counts now have been found in China. These statistics reflect an "upregulation" of this gene which has been linked to the lethality of influenza viruses. When factored in with previous findings, this suggests that the H5N1 outbreak in Indonesia is not over and that the next country to show an increase in human cases and mortality rate will be China.

Ekomed's Botanical Immunomodulator Proves Effective for Seasonal Flu Treatment
Ekomed LLC, a developer and manufacturer of herbal medicines, has concluded a clinical study of phyto-pharmaceutical Dzherelo (Immunoxel) for the seasonal flu indication.

Influenza- causes, symptoms and treatment
Influenza is commonly known as flu, it is an infectious disease of birds that can cause by RNA viruses. It is a contagious respiratory illness that is caused by influenza virus. Actually it is a viral infection that affects throat, nose, bronchi and in some cases it also affects lungs.

Natural Prevention & Treatment For The Flu: What Your Doctor May Not Know
Flu can affect 10 to 30 percent of the U.S.

Amantadine to Prevent Influenza
Amantadine is a synthetic anti-viral drug. Amantadine is useful in the treatment of parkinson's syndrome. It is useful as an adjunct in patients who do not tolerate optimal doses of levodopa alone.

What to do About the Flu - Dr's Top 10 Tips For Flu Prevention
With the flu season fast approaching it's important that you do what you can to avoid it - especially if you are within an at risk category based on your age or general health One thing alone will not be enough - for example you can't expect a flu shot by itself to keep you immune

Influenza Antibody Spray Success: Opens New Approach to Respiratory Disease Control

MELBOURNE, Australia & NEW YORK (Business Wire EON) August 21, 2008 -- Working with an animal influenza challenge model in the laboratory of Professor Loreena Brown at the Department of Microbiology and Immunology, University of Melbourne, scientists successfully completed a series of proof-in-principal experiments. These experiments using an animal model designed specifically to test influenza prevention and treatment, demonstrated the ability of Anadis' all natural antibody nasal spray formulation to "switch-off" virus replication at the respiratory tract lining. The studies indicated a significant impact of single and daily dose of the Anadis polyclonal antibodies in reducing the likelihood of infection and reducing the severity of those infected with influenza.

Scientists from the University of Melbourne and Anadis teams are in the process of submitting data for publication and intend to present the details at an upcoming influenza control conference.

Anadis CEO Dr. Zeil Rosenberg stated, "Our new topical spray approach to protecting individuals during seasonal or epidemic flu outbreaks is a radical new paradigm to protect people from these influenza viruses. The fact that the Anadis antibodies are all natural and topically applied means we may have a very safe and effective new approach to provide immediate protection to all persons and be able to address multiple virus strains. We know from current failures in vaccine protection among many persons this past year that indeed novel approaches like this are urgently needed."

Anadis VP for Business Development Oren Fuerst further noted, "This work supports an aggressive commercial strategy expanding our intellectual property position in this unique area. Our approach shows for the first time a cost effective method of fighting influenza using antibodies. We plan to move on our own and with partners to bring this revolutionary product to market."

Anadis' polyclonal antibodies are obtained using its own proprietary approach to vaccinating dairy cows and then leveraging advanced dairy industry methods collect first-milking colostrum under GMP conditions, where it is further formulated as a spray dried powder, for later reconstitution as an all natural nasal spray.